Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
OBIO on Nasdaq
Shares outstanding
60,621,452
Price per share
$4.15
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
21,701,707
Total reported value
$90,065,005
% of total 13F portfolios
0%
Share change
-486,142
Value change
-$304,511
Number of holders
63
Price from insider filings
$4.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 20% +29% $49,561,068 +$15,090,906 11,942,426 +44% RTW Investments, LP 23 Feb 2026
Medtronic plc 15% $14,848,357 5,868,916 Medtronic plc 31 Dec 2024
PERCEPTIVE ADVISORS LLC 10% $14,085,110 5,679,480 Perceptive Advisors LLC 30 Sep 2025
Tasso Partners, LLC 5.5% $7,684,508 3,098,592 Dana Lorenzo 15 Nov 2025
BlackRock, Inc. 3.7% $3,619,674 1,430,701 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 63 institutional investors reported holding 21,701,707 shares of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO). This represents 36% of the company’s total 60,621,452 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RTW INVESTMENTS, LP 14% 8,306,063 0% 0.35% $34,470,161
PERCEPTIVE ADVISORS LLC 8.5% 5,127,256 -3.1% 0.39% $21,278,112
VANGUARD GROUP INC 2.6% 1,604,556 +8.3% 0% $6,658,907
Alyeska Investment Group, L.P. 1.6% 1,000,000 -27% 0.01% $4,150,000
BlackRock, Inc. 1% 630,901 -5% 0% $2,618,239
Affinity Asset Advisors, LLC 0.94% 572,804 -21% 0.17% $2,377,137
GEODE CAPITAL MANAGEMENT, LLC 0.78% 473,363 +22% 0% $1,965,479
PRICE T ROWE ASSOCIATES INC /MD/ 0.6% 364,645 -14% 0% $1,514,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.44% 263,788 +46% 0% $1,094,720
Knott David M Jr 0.41% 250,000 +28% 0.48% $1,037,500
MILLENNIUM MANAGEMENT LLC 0.4% 243,473 -35% 0% $1,010,413
683 Capital Management, LLC 0.34% 204,076 0.07% $846,915
JANE STREET GROUP, LLC 0.29% 173,765 +165% 0% $721,124
MARSHALL WACE, LLP 0.28% 171,681 0% $712,476
Point72 Asset Management, L.P. 0.27% 161,946 0% $672,076
STATE STREET CORP 0.26% 159,033 +58% 0% $659,987
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.26% 155,130 +58% 0% $643,790
RENAISSANCE TECHNOLOGIES LLC 0.25% 151,300 -60% 0% $627,895
GOLDMAN SACHS GROUP INC 0.22% 134,073 +467% 0% $556,403
DAFNA Capital Management LLC 0.21% 126,841 -65% 0.12% $526,390
NORTHERN TRUST CORP 0.18% 110,899 +8.1% 0% $460,231
Qube Research & Technologies Ltd 0.18% 106,742 +312% 0% $442,979
ExodusPoint Capital Management, LP 0.16% 95,635 0% $396,885
BARCLAYS PLC 0.16% 94,517 +9451600% 0% $392,246
IFP Advisors, Inc 0.14% 86,698 0% 0.01% $359,797

Institutional Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 21,701,707 $90,065,005 -$304,511 $4.15 63
2025 Q3 22,434,285 $55,672,466 +$11,747,809 $2.48 49
2025 Q2 17,679,478 $47,383,339 -$3,869,274 $2.68 57
2025 Q1 18,991,589 $81,285,133 -$1,022,777 $4.28 55
2024 Q4 19,251,082 $77,005,657 -$602,359 $4.00 53
2024 Q3 19,025,849 $97,782,881 +$23,796,821 $5.14 47
2024 Q2 14,216,993 $115,871,788 +$7,254,151 $8.15 46
2024 Q1 13,334,624 $70,275,199 +$299,341 $5.27 42
2023 Q4 13,269,980 $121,156,215 +$1,621,325 $9.13 39
2023 Q3 13,093,349 $114,176,966 +$20,438,436 $8.72 42
2023 Q2 10,783,562 $75,485,512 +$5,117,242 $7.00 39
2023 Q1 9,872,658 $193,184,972 +$179,728,876 $19.57 22
2022 Q4 685,801 $6,851,000 +$6,851,000 $9.99 1